Identification and characterization of multiple splice forms of the human interleukin-23 receptor α chain in mitogen-activated leukocytes

Genes and Immunity

Volumn 9, Issue 7, 2008, Pages 631-639

  Kan, S H ^a   Mancini, G ^a   Gallagher, G ^a  

^a HUMIGEN LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 23 RECEPTOR ALPHA; MESSENGER RNA; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ARTICLE; AUTOINFLAMMATORY DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXTRACELLULAR SPACE; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; LIGAND BINDING; LYMPHOCYTE DIFFERENTIATION; MITOGENESIS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA SEQUENCE; RNA TRANSLATION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TH17 CELL;

ALTERNATIVE SPLICING; CELLS, CULTURED; CROHN DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MITOGENS; PROTEIN ISOFORMS; PROTEIN SUBUNITS; RECEPTORS, INTERLEUKIN;

EID: 67651148557     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2008.64     Document Type: Article

References (27)

1. Parham C, Chirica M, Timans J, Vaisberg E, Travis M, Cheung J et al A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 2002; 168: 5699-5708.
2. Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ. IL-12 and IL-23: Master regulators of innate and adaptive immunity. Immunol Rev 2004; 202: 96-105.
3. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007; 445: 648-651.
4. Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 2004; 199 125-130.
5. van de Vosse E, Lichtenauer-Kaligis EG, van Dissel JT, Ottenhoff TH. Genetic variations in the interleukin-12/interleukin-23 receptor (beta1) chain, and implications for IL-12 and IL-23 receptor structure and function. Immunogenetics 2003; 54: 817-829.
6. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25: 821-852.
7. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007; 282: 9358-9363.
8. Capon F, Di Meglio P, Szaub J, Prescott NJ, Dunster C, Baumber L et al. Sequence variants in the genes for the interleukin-23 receptor (IL-23R) and its ligand (IL-12B) confer protection against psoriasis. Hum Genet 2007; 122: 201-206.
9. Nair RP, Ruether A, Stuart PE, Jenisch S, Tejasvi T, Hiremagalore R et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol 2008; 128: 1653-1661.
10. Rueda B, Orozco G, Raya E, Fernandez-Sueiro JL, Mulero J, Blanco FJ et al. The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis 2008; e-pub ahead of print.
11. Illes Z, Safrany E, Peterfalvi A, Magyari L, Farago B, Pozsonyi E et al. 3′UTR C2370A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosis. Neurosci Lett 2008; 431: 36-38.
12. Roos IM, Kockum I, Hillert J. The interleukin 23 receptor gene in multiple sclerosis: A case-control study. J Neuroimmunol 2008; 194: 173-180.
13. Begovich AB, Chang M, Caillier SJ, Lew D, Catanese JJ, Wang J et al The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis. Hum Immunol 2007; 68: 934-937.
14. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ et al A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461-1463.
15. Raelson JV, Little RD, Ruether A, Fournier H, Paquin B, Van Eerdewegh P et al. Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci. Proc Natl Acad Sci USA 2007; 104: 14747-14752.
16. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A et al. Association scan of 14 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39: 1329-1337.
17. Rahman P, Inman RD, Gladman DD, Reeve JP, Peddle L, Maksymowych WP. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum 2008; 58: 1020-1025.
18. Liu Y, Helms C, Liao W, Zaba LC, Duan S, Gardner J et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 2008; 4: E1000041.
19. Roberts RL, Gearry RB, Hollis-Moffatt JE, Miller AL, Reid J, Abkevich V et al. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. Am J Gastroenterol 2007; 102: 2754-2761.
20. Zhang XY, Zhang HJ, Zhang Y, Fu YJ, He J, Zhu LP et al. Identification and expression analysis of alternatively spliced isoforms of human interleukin-23 receptor gene in normal lymphoid cells and selected tumor cells. Immunogenetics 2006; 57: 934-943.
21. Mancini G, Kan S-h, Gallagher G. A novel insertion variant of the human IL-23 receptor alpha chain transcript. Genes Immun 2008; 9: 566-569
22. Graveley BR. Alternative splicing: Increasing diversity in the proteomic world. Trends Genet 2001; 17: 100-107.
23. Black DL. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 2003; 72: 291-336.
24. Lewis BP, Green RE, Brenner SE. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci USA 2003; 100: 189-192.
25. Maquat LE. Nonsense-mediated mRNA decay: Splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol 2004; 5: 89-99.
26. Baker KE, Parker R. Nonsense-mediated mRNA decay: Terminating erroneous gene expression. Curr Opin Cell Biol 2004; 16: 293-299.
27. Levine SJ. Mechanisms of soluble cytokine receptor generation. J Immunol 2004; 173: 5343-5348.